Cargando…

Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine

The leading malaria vaccine in development is the circumsporozoite protein (CSP)-based particle vaccine, RTS,S, which targets the pre-erythrocytic stage of Plasmodium falciparum infection. It induces modest levels of protective efficacy, thought to be mediated primarily by CSP-specific antibodies. W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Collins, Katharine A., Snaith, Rebecca, Cottingham, Matthew G., Gilbert, Sarah C., Hill, Adrian V. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395940/ https://www.ncbi.nlm.nih.gov/pubmed/28422178 http://dx.doi.org/10.1038/srep46621

Ejemplares similares

Ultra-low dose immunization and multi-component vaccination strategies enhance protection against malaria in mice
por: Collins, Katharine A., et al.
Publicado: (2021)

Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines
por: Caldeira, Jerri C., et al.
Publicado: (2020)

Immunogenicity and protective potency of Norovirus GII.17 virus-like particle-based vaccine
por: Chen, Wei, et al.
Publicado: (2020)

Inclusion of cGAMP within virus‐like particle vaccines enhances their immunogenicity
por: Chauveau, Lise, et al.
Publicado: (2021)

Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activity
por: Chan, Jo-Anne, et al.
Publicado: (2019)

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice
por: Warimwe, George M, et al.
Publicado: (2013)

Development of a Plasmodium vivax malaria vaccine for clinical applications using transgenic parasites, virus-like particles and recombinant viruses
por: Reyes-Sandoval, Arturo, et al.
Publicado: (2014)

Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease
por: Davenport, Bennett J., et al.
Publicado: (2022)

Virus-like Particle Vaccines of Infectious Bursal Disease Virus Expressed in Escherichia coli Are Highly Immunogenic and Protect against Virulent Strain
por: Ji, Pengchao, et al.
Publicado: (2023)

Comparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidates
por: Longley, Rhea J., et al.
Publicado: (2015)

Pigs Immunized with the Virus-like Particle Vaccine Are Protected against the Hepatitis E-3 Virus
por: Go, Hyeon-Jeong, et al.
Publicado: (2021)

Design and immunogenicity assessment of HIV-1 virus-like particles as a candidate vaccine
por: Zhang, XiZhen, et al.
Publicado: (2011)

Low immunogenicity of malaria pre‐erythrocytic stages can be overcome by vaccination
por: Müller, Katja, et al.
Publicado: (2021)

Codelivery of improved immune complex and virus-like particle vaccines containing Zika virus envelope domain III synergistically enhances immunogenicity
por: Diamos, Andrew G., et al.
Publicado: (2020)

Potent Protective Immune Responses to Senecavirus Induced by Virus-Like Particle Vaccine in Pigs
por: Mu, Suyu, et al.
Publicado: (2020)

Immunization with Virus-Like Particle Vaccine Protects Rabbits against Hepatitis E-3 Virus Infection
por: Go, Hyeon-Jeong, et al.
Publicado: (2022)

Immunogenicity and safety of virus-like particle of the porcine encephalomyocarditis virus in pig
por: Jeoung, Hye-Young, et al.
Publicado: (2011)

Enhancing the immunogenicity of tumour lysate-loaded dendritic cell vaccines by conjugation to virus-like particles
por: Win, S J, et al.
Publicado: (2012)

Flagellin/Virus-like Particle Hybrid Platform with High Immunogenicity, Safety, and Versatility for Vaccine Development
por: Zhao, Yiwen, et al.
Publicado: (2022)

Transgene Optimization, Immunogenicity and In Vitro Efficacy of Viral Vectored Vaccines Expressing Two Alleles of Plasmodium falciparum AMA1
por: Biswas, Sumi, et al.
Publicado: (2011)

Immunogenicity and protective efficacy of human metapneumovirus virus-like particles produced by a recombinant baculovirus in mice
por: Ma, Fenlian, et al.
Publicado: (2023)

Qß Virus-like particle-based vaccine induces robust immunity and protects against tauopathy
por: Maphis, Nicole M., et al.
Publicado: (2019)

Balanced T and B cell responses are required for immune protection against Powassan virus in virus-like particle vaccination
por: Stone, E. Taylor, et al.
Publicado: (2022)

4-1BBL Enhances CD8(+) T Cell Responses Induced by Vectored Vaccines in Mice but Fails to Improve Immunogenicity in Rhesus Macaques
por: Spencer, Alexandra J., et al.
Publicado: (2014)

Immunogenicity and Protective Effect of a Virus-Like Particle Containing the SAG1 Antigen of Toxoplasma gondii as a Potential Vaccine Candidate for Toxoplasmosis
por: Choi, Won Hyung, et al.
Publicado: (2020)

Immunogenicity of plant‐produced African horse sickness virus‐like particles: implications for a novel vaccine
por: Dennis, Susan J., et al.
Publicado: (2017)

Dose immunogenicity study of a plant-produced influenza virus-like particle vaccine in layer hens
por: Abolnik, Celia, et al.
Publicado: (2022)

A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity
por: Dicks, Matthew D. J., et al.
Publicado: (2012)

Construction and Immunogenicity of Virus-Like Particles of Feline Parvovirus from the Tiger
por: Jiao, Cuicui, et al.
Publicado: (2020)

Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers
por: Nooraei, Saghi, et al.
Publicado: (2021)

Antigenicity and immunogenicity of chikungunya virus-like particles from mosquito cells
por: Tsai, Shan-Ko, et al.
Publicado: (2022)

Immunogenicity and Efficacy of Monovalent and Bivalent Formulations of a Virus-Like Particle Vaccine against SARS-CoV-2
por: Resch, Matthew D., et al.
Publicado: (2022)

Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice
por: Dicks, Matthew D. J., et al.
Publicado: (2015)

Immunogenicity and Protective Capacity of a Virus-like Particle Vaccine against Chlamydia trachomatis Type 3 Secretion System Tip Protein, CT584
por: Webster, Everett, et al.
Publicado: (2022)

104 Immunogenicity and Safety Aspects of Adeno-Associated Virus–Like Particles (AAVLPS) as Carriers for B-Cell Vaccines
por: Jensen-Jarolim, Erika, et al.
Publicado: (2012)

A scalable and highly immunogenic virus‐like particle‐based vaccine against SARS‐CoV‐2
por: Mohsen, Mona O., et al.
Publicado: (2021)

Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax
por: Cabral-Miranda, Gustavo, et al.
Publicado: (2017)

Preparation and immunogenicity of influenza virus-like particles using nitrocellulose membrane filtration
por: Park, Young Chan, et al.
Publicado: (2017)

Immunogenicity of Plant-Produced Human Papillomavirus (HPV) Virus-Like Particles (VLPs)
por: Naupu, Paulina N., et al.
Publicado: (2020)

Construction of Porcine Epidemic Diarrhea Virus-Like Particles and Its Immunogenicity in Mice
por: Kim, Jihee, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t6p3ebrg55ge2gcp41qlgves0u